← Back

Wire · opportunities

BioTech Breakthrough Awards Names Medidata's Synthetic

Published

10 November 2026

Topic

opportunities

◆ Sectors

Biotech

◆ Geography

United States

◆ Source

Read at globenewswire.com →

◆ Verified

Fusion42 · 10 November 2026 · Fusion42 review

Medidata’s Synthetic Control Arm®, an AI-powered external control arm solution, received the 2026 BioTech Breakthrough Award for Real World Evidence Solution of the Year. The technology enables more efficient and patient-friendly clinical trials by replacing or reducing traditional randomized control arms, demonstrated through FDA-accepted designs and EMA-authorized therapies.

This Wire brief sits within Fusion42's coverage of Biotech.

◆ ◆ The Wire takeaway

You can cut patient enrolment in randomized trial arms significantly by deploying AI-powered external control arms like Medidata’s, opening faster pathways to regulatory approvals and easing patient recruitment. This approach lets you reconfigure trial designs to reduce costs and speed evidence generation in life sciences.

◆ Coverage

1 source · 10 Nov 2026

◆ Related on Wire

◆ Topics

Biotechclinical-trialsaireal-world-evidenceregulatory-acceptancepatient-equity